Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duck-Woo Kim

Showing results (91-100 of 165) with videos related to

Pageof 17
Sort By:
Oncology Letters|June 13, 2019
Prognostic implication of ABC transporters and cancer stem cell markers in patients with stage III colon cancer receiving adjuvant FOLFOX-4 chemotherapySong-Hee Han, Jin Won Kim, Milim Kim, et al.
BMC Cancer|April 9, 2014
P21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancerSung Hoon Sim, Mi-Hyun Kang, Yu Jung Kim, et al.
Annals of Surgical Treatment and Research|June 13, 2024
Comparative analysis of different surgical approaches for recurrent inguinal hernia: a single-center observational studyMi Jeong Choi, Kang-Seok Lee, Heung-Kwon Oh, et al.
Annals of Surgical Oncology|January 27, 2019
Impact of Family History on Prognosis of Patients with Sporadic Colorectal CancerSoo Young Lee, Duck-Woo Kim, Sung Il Kang, et al.
Japanese Journal of Clinical Oncology|December 4, 2012
Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in KoreaJi-Yeon Kim, Yu Jung Kim, Keun-Wook Lee, et al.
Journal of Translational Medicine|August 3, 2017
Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancerYoonjin Kwak, Sumi Yun, Soo Kyung Nam, et al.
Cancer|March 15, 2006
Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer?Duck-Woo Kim, Dae Yong Kim, Tae Hyun Kim, et al.
JAMA Surgery|June 24, 2026
Inferior Mesenteric Artery Ligation Level and Anastomotic Leakage in Low Anterior Resection: A Randomized Clinical TrialChang Hyun Kim, Soo Yeun Park, Soo Young Lee, et al.
Familial Cancer|June 7, 2012
Microsatellite instability testing in Korean patients with colorectal cancerJung Ryul Oh, Duck-Woo Kim, Hye Seung Lee, et al.
Annals of Surgical Treatment and Research|August 13, 2021
Oncologic comparison between nonradical management and total mesorectal excision in good responders after chemoradiotherapy in patients with mid-to-low rectal cancerJa Kyung Lee, Jung Rae Cho, Kwang-Seop Song, et al.
Pageof 17

Showing results (91-100 of 165) with videos related to

Sort By:
Pageof 17
Oncology Letters|June 13, 2019
Prognostic implication of ABC transporters and cancer stem cell markers in patients with stage III colon cancer receiving adjuvant FOLFOX-4 chemotherapySong-Hee Han, Jin Won Kim, Milim Kim, et al.
BMC Cancer|April 9, 2014
P21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancerSung Hoon Sim, Mi-Hyun Kang, Yu Jung Kim, et al.
Annals of Surgical Treatment and Research|June 13, 2024
Comparative analysis of different surgical approaches for recurrent inguinal hernia: a single-center observational studyMi Jeong Choi, Kang-Seok Lee, Heung-Kwon Oh, et al.
Annals of Surgical Oncology|January 27, 2019
Impact of Family History on Prognosis of Patients with Sporadic Colorectal CancerSoo Young Lee, Duck-Woo Kim, Sung Il Kang, et al.
Japanese Journal of Clinical Oncology|December 4, 2012
Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in KoreaJi-Yeon Kim, Yu Jung Kim, Keun-Wook Lee, et al.
Journal of Translational Medicine|August 3, 2017
Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancerYoonjin Kwak, Sumi Yun, Soo Kyung Nam, et al.
Cancer|March 15, 2006
Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer?Duck-Woo Kim, Dae Yong Kim, Tae Hyun Kim, et al.
JAMA Surgery|June 24, 2026
Inferior Mesenteric Artery Ligation Level and Anastomotic Leakage in Low Anterior Resection: A Randomized Clinical TrialChang Hyun Kim, Soo Yeun Park, Soo Young Lee, et al.
Familial Cancer|June 7, 2012
Microsatellite instability testing in Korean patients with colorectal cancerJung Ryul Oh, Duck-Woo Kim, Hye Seung Lee, et al.
Annals of Surgical Treatment and Research|August 13, 2021
Oncologic comparison between nonradical management and total mesorectal excision in good responders after chemoradiotherapy in patients with mid-to-low rectal cancerJa Kyung Lee, Jung Rae Cho, Kwang-Seop Song, et al.
Pageof 17